Up to 50,210 fresh COVID-19 cases in India, 8.5% higher than yesterday; 83.64 lakh total cases so far, with 1,24,315 deaths in all recorded till now - 704 in the past 24 hours alone. Up to 77,11,809 have recovered across the country till now, with over 55,000 in the past 24 hours alone. All this is based on a cumulative 11,42,08,384 samples tested up to Wednesday.
The average number of deaths per day has also fallen in the past seven weeks, from up to 1,165 between September 16 and 22 to 513 between October 28 and November 3, Health Ministry data shows.
Delhi recorded its highest ever daily spike with 6,842 new cases in the past 24 hours - the second straight day crossing 6,000. On Wednesday, it had recorded its second-highest daily cases at 6,725.
Meanwhile, more than 99,000 coronavirus cases were recorded in the United States in the past 24 hours, a new daily record, according to a tally by Johns Hopkins University.
The country reported 99,660 new infections between 8:30 pm Tuesday and 8:30 pm Wednesday (0130 GMT), and 1,112 deaths, the tally by the Baltimore-based school showed a day after American's went voted to choose their next president.
More than 9.4 million people have been infected and 2,33,000 have died in the US so far during the pandemic, by far the worst tolls in absolute terms globally.
Here are the Highlights on Coronavirus (COVID-19) Cases:
AstraZeneca, the British drugmaker working on one of the world's leading COVID-19 vaccine candidates, beat third-quarter sales estimates on Thursday and reiterated it expects data from late-stage trials of the vaccine later this year.
Delirium or mental confusion accompanied by fever could be an early symptom of COVID-19, particularly in elderly patients, according to a review of studies.
Bangladesh signed a deal with the Serum Institute of India on Thursday to buy 30 million doses of a potential coronavirus vaccine being developed by British drugmaker AstraZeneca.